Transcatheter Embolization and Occlusion Devices | Japan | 2018 | Market Analysis
Although device approval in Japan lags behind other developed countries, the Japanese TEO device market will be dynamic as a result of a strong product pipeline and the emergence of positive clinical trial data, which will lead to multiple products entering the market and increasing physician adoption of new technology through 2026.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in Japan across a 10-year period.